| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000232342.3 |
Ponatinib |
Breast invasive carcinoma |
0.038287496 |
Resistant |
| ENSG00000232342.3 |
Ponatinib |
Brain lower grade glioma |
0.018079328 |
Resistant |
| ENSG00000232342.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.049890631 |
Sensitive |
